Cargando…

Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study

Background  Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously examined intermediate-risk patients from hospital data and...

Descripción completa

Detalles Bibliográficos
Autores principales: Robbins, Emma C., Wooldrage, Kate, Stenson, Iain, Pack, Kevin, Duffy, Stephen, Weller, David, Levin, Theodore, Conell, Carol, Wright, Suzanne, Nickerson, Claire, Martin, Jessica, Cross, Amanda J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007389/
https://www.ncbi.nlm.nih.gov/pubmed/32814350
http://dx.doi.org/10.1055/a-1217-0155
_version_ 1783672477430317056
author Robbins, Emma C.
Wooldrage, Kate
Stenson, Iain
Pack, Kevin
Duffy, Stephen
Weller, David
Levin, Theodore
Conell, Carol
Wright, Suzanne
Nickerson, Claire
Martin, Jessica
Cross, Amanda J.
author_facet Robbins, Emma C.
Wooldrage, Kate
Stenson, Iain
Pack, Kevin
Duffy, Stephen
Weller, David
Levin, Theodore
Conell, Carol
Wright, Suzanne
Nickerson, Claire
Martin, Jessica
Cross, Amanda J.
author_sort Robbins, Emma C.
collection PubMed
description Background  Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously examined intermediate-risk patients from hospital data and identified a higher-risk subgroup who benefited from surveillance and a lower-risk subgroup who may not require surveillance. This study explored whether these findings apply in individuals undergoing CRC screening. Methods  This retrospective study used data from the UK Flexible Sigmoidoscopy Screening Trial (UKFSST), English CRC screening pilot (ECP), and US Kaiser Permanente CRC prevention program (KPCP). Screening participants (50 – 74 years) classified as intermediate-risk at baseline colonoscopy were included. CRC data were available through 2006 (KPCP) or 2014 (UKFSST, ECP). Lower- and higher-risk subgroups were defined using our previously identified baseline risk factors: higher-risk participants had incomplete colonoscopies, poor bowel preparation, adenomas ≥ 20 mm or with high-grade dysplasia, or proximal polyps. We compared CRC incidence in these subgroups and in the presence vs. absence of surveillance using Cox regression. Results  Of 2291 intermediate-risk participants, 45 % were classified as higher risk. Median follow-up was 11.8 years. CRC incidence was higher in the higher-risk than lower-risk subgroup (hazard ratio [HR] 2.08, 95 % confidence interval [CI] 1.07 – 4.06). Surveillance reduced CRC incidence in higher-risk participants (HR 0.35, 95 %CI 0.14 – 0.86) but not statistically significantly so in lower-risk participants (HR 0.41, 95 %CI 0.12 – 1.38). Conclusion  As previously demonstrated for hospital patients, screening participants classified as intermediate risk comprised two risk subgroups. Surveillance clearly benefited the higher-risk subgroup.
format Online
Article
Text
id pubmed-8007389
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-80073892021-03-31 Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study Robbins, Emma C. Wooldrage, Kate Stenson, Iain Pack, Kevin Duffy, Stephen Weller, David Levin, Theodore Conell, Carol Wright, Suzanne Nickerson, Claire Martin, Jessica Cross, Amanda J. Endoscopy Background  Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously examined intermediate-risk patients from hospital data and identified a higher-risk subgroup who benefited from surveillance and a lower-risk subgroup who may not require surveillance. This study explored whether these findings apply in individuals undergoing CRC screening. Methods  This retrospective study used data from the UK Flexible Sigmoidoscopy Screening Trial (UKFSST), English CRC screening pilot (ECP), and US Kaiser Permanente CRC prevention program (KPCP). Screening participants (50 – 74 years) classified as intermediate-risk at baseline colonoscopy were included. CRC data were available through 2006 (KPCP) or 2014 (UKFSST, ECP). Lower- and higher-risk subgroups were defined using our previously identified baseline risk factors: higher-risk participants had incomplete colonoscopies, poor bowel preparation, adenomas ≥ 20 mm or with high-grade dysplasia, or proximal polyps. We compared CRC incidence in these subgroups and in the presence vs. absence of surveillance using Cox regression. Results  Of 2291 intermediate-risk participants, 45 % were classified as higher risk. Median follow-up was 11.8 years. CRC incidence was higher in the higher-risk than lower-risk subgroup (hazard ratio [HR] 2.08, 95 % confidence interval [CI] 1.07 – 4.06). Surveillance reduced CRC incidence in higher-risk participants (HR 0.35, 95 %CI 0.14 – 0.86) but not statistically significantly so in lower-risk participants (HR 0.41, 95 %CI 0.12 – 1.38). Conclusion  As previously demonstrated for hospital patients, screening participants classified as intermediate risk comprised two risk subgroups. Surveillance clearly benefited the higher-risk subgroup. Georg Thieme Verlag KG 2021-04 2020-08-19 /pmc/articles/PMC8007389/ /pubmed/32814350 http://dx.doi.org/10.1055/a-1217-0155 Text en © 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Robbins, Emma C.
Wooldrage, Kate
Stenson, Iain
Pack, Kevin
Duffy, Stephen
Weller, David
Levin, Theodore
Conell, Carol
Wright, Suzanne
Nickerson, Claire
Martin, Jessica
Cross, Amanda J.
Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study
title Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study
title_full Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study
title_fullStr Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study
title_full_unstemmed Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study
title_short Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study
title_sort heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007389/
https://www.ncbi.nlm.nih.gov/pubmed/32814350
http://dx.doi.org/10.1055/a-1217-0155
work_keys_str_mv AT robbinsemmac heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT wooldragekate heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT stensoniain heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT packkevin heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT duffystephen heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT wellerdavid heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT levintheodore heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT conellcarol heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT wrightsuzanne heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT nickersonclaire heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT martinjessica heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy
AT crossamandaj heterogeneityincolorectalcancerincidenceamongpeoplerecommended3yearlysurveillancepostpolypectomyavalidationstudy